2 ms·
It was limited to prescription drug DTC, but yes, you're point about cost-effectiveness is true. That typically falls on the patient and their insurance, but t
by refurb 6y ago
It was limited to prescription drug DTC, but yes, you're point about cost-effectiveness is true. That typically falls on the patient and their insurance, but the system doesn't make the ability to take cost into account very easy at all (i.e. you usually find out the cost when paying for the Rx).